These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7531700)

  • 1. Identification and characterization of a functional murine FLT3 isoform produced by exon skipping.
    Lavagna C; Marchetto S; Birnbaum D; Rosnet O
    J Biol Chem; 1995 Feb; 270(7):3165-71. PubMed ID: 7531700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form.
    Miyazawa K; Williams DA; Gotoh A; Nishimaki J; Broxmeyer HE; Toyama K
    Blood; 1995 Feb; 85(3):641-9. PubMed ID: 7530502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
    Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
    J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p85 subunit of PI3 kinase does not bind to human Flt3 receptor, but associates with SHP2, SHIP, and a tyrosine-phosphorylated 100-kDa protein in Flt3 ligand-stimulated hematopoietic cells.
    Zhang S; Broxmeyer HE
    Biochem Biophys Res Commun; 1999 Jan; 254(2):440-5. PubMed ID: 9918857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase.
    Maroc N; Rottapel R; Rosnet O; Marchetto S; Lavezzi C; Mannoni P; Birnbaum D; Dubreuil P
    Oncogene; 1993 Apr; 8(4):909-18. PubMed ID: 8384358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells.
    Rosnet O; Schiff C; Pébusque MJ; Marchetto S; Tonnelle C; Toiron Y; Birg F; Birnbaum D
    Blood; 1993 Aug; 82(4):1110-9. PubMed ID: 8394751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic organization of the flt-1 gene encoding for vascular endothelial growth factor (VEGF) receptor-1 suggests an intimate evolutionary relationship between the 7-Ig and the 5-Ig tyrosine kinase receptors.
    Kondo K; Hiratsuka S; Subbalakshmi E; Matsushime H; Shibuya M
    Gene; 1998 Feb; 208(2):297-305. PubMed ID: 9524283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase.
    Yee KW; O'Farrell AM; Smolich BD; Cherrington JM; McMahon G; Wait CL; McGreevey LS; Griffith DJ; Heinrich MC
    Blood; 2002 Oct; 100(8):2941-9. PubMed ID: 12351406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.
    Nakao M; Yokota S; Iwai T; Kaneko H; Horiike S; Kashima K; Sonoda Y; Fujimoto T; Misawa S
    Leukemia; 1996 Dec; 10(12):1911-8. PubMed ID: 8946930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fms-like tyrosine kinase 3 catalytic domain can transduce a proliferative signal in FDC-P1 cells that is qualitatively similar to the signal delivered by c-Fms.
    Rossner MT; McArthur GA; Allen JD; Metcalf D
    Cell Growth Differ; 1994 May; 5(5):549-55. PubMed ID: 8049161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells.
    Lyman SD; James L; Vanden Bos T; de Vries P; Brasel K; Gliniak B; Hollingsworth LT; Picha KS; McKenna HJ; Splett RR
    Cell; 1993 Dec; 75(6):1157-67. PubMed ID: 7505204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificities and identification of a putative binding site for PI3K in the carboxy tail of the murine Flt3 receptor tyrosine kinase.
    Rottapel R; Turck CW; Casteran N; Liu X; Birnbaum D; Pawson T; Dubreuil P
    Oncogene; 1994 Jun; 9(6):1755-65. PubMed ID: 8183574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute myeloid leukemia (AML).
    Kindler T; Breitenbuecher F; Kasper S; Estey E; Giles F; Feldman E; Ehninger G; Schiller G; Klimek V; Nimer SD; Gratwohl A; Choudhary CR; Mueller-Tidow C; Serve H; Gschaidmeier H; Cohen PS; Huber C; Fischer T
    Blood; 2005 Jan; 105(1):335-40. PubMed ID: 15345593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene.
    Lyman SD; James L; Zappone J; Sleath PR; Beckmann MP; Bird T
    Oncogene; 1993 Apr; 8(4):815-22. PubMed ID: 7681159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor.
    Tse KF; Allebach J; Levis M; Smith BD; Bohmer FD; Small D
    Leukemia; 2002 Oct; 16(10):2027-36. PubMed ID: 12357354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7.
    Orlic D; Anderson S; Biesecker LG; Sorrentino BP; Bodine DM
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4601-5. PubMed ID: 7538677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel type of alternative splicing of a tyrosine kinase receptor. Juxtamembrane deletion of the c-met protein kinase C serine phosphorylation regulatory site.
    Lee CC; Yamada KM
    J Biol Chem; 1994 Jul; 269(30):19457-61. PubMed ID: 7518457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of FMS, KIT and FLT3 in hematopoietic malignancies.
    Birg F; Rosnet O; Carbuccia N; Birnbaum D
    Leuk Lymphoma; 1994 Apr; 13(3-4):223-7. PubMed ID: 7519507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of GFRalpha1 receptor splicing variants with different biochemical properties is modulated during kidney development.
    Charlet-Berguerand N; Le Hir H; Incoronato M; di Porzio U; Yu Y; Jing S; de Franciscis V; Thermes C
    Cell Signal; 2004 Dec; 16(12):1425-34. PubMed ID: 15381258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic structure of the downstream part of the human FLT3 gene: exon/intron structure conservation among genes encoding receptor tyrosine kinases (RTK) of subclass III.
    Agnès F; Shamoon B; Dina C; Rosnet O; Birnbaum D; Galibert F
    Gene; 1994 Aug; 145(2):283-8. PubMed ID: 8056344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.